Gemeinschaftspraxis Dr. med. Josef und Dr. med. Wilma Großkopf
- Address
- Ahornstraße 2a, 94574 Wallerfing, Germany
Cardiovascular Diseases
The research at the practice explores heart failure and aims to evaluate a novel drug combination for reducing cardiovascular deaths and hospital visits.
- Combination therapy with emerging agents
- Time to first cardiovascular event
- Patient-reported outcomes and quality of life
Gemeinschaftspraxis Dr. med. Josef und Dr. med. Wilma Großkopf partners with investigators to advance treatment options for this condition.
Digestive System Diseases
Clinical trials focus on functional gastrointestinal disorders, testing the herbal formulation Menthacarin for symptom control and gut barrier health.
- Symptom change and tolerability assessment
- Evaluation of gut permeability markers
- Impact on quality of life and treatment satisfaction
The Wallerfing site engages a broad patient population to improve digestive health outcomes.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Gemeinschaftspraxis Dr. med. Josef und Dr. med. Wilma Großkopf
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of the Efficacy and Safety of BI 690517 and Empagliflozin in Patients with Symptomatic Heart Failure and LVEF ≥40%: A Phase III Randomized Controlled Trial | Boehringer Ingelheim International GmbH | Phase III | Recruiting | Oct 2024 | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Bi 690517 | 2 | Unknown | 2024-10-18 | 2025-08-22 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.